Patents

US 12655448 B2: Helper-dependent adenoviral gene therapy delivery and expression system

Granted
2026-06-16
Filed
2021-06-25 application 17358904
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention relates to gene therapy delivery and expression systems comprising at least one helper-dependent adenoviral vector containing a nucleic acid sequence encoding for proteoglycan 4 (PRG4) or a biologically active fragment thereof. The invention further relates to a pharmaceutical composition comprising a therapeutically effective amount of at least one helper-dependent adenoviral vector containing said nucleic acid sequence encoding for proteoglycan 4 (PRG4), or a homolog thereof from any other species, or a biologically active fragment thereof. The invention also relates to the use of the novel gene therapy delivery and expression system according to the invention for use in the prevention and/or treatment of camptodactyly-arthropathy-coxa vara-pericarditis (CACP), or a musculoskeletal disorder such as a joint disorder or joint disease.

Source: PTBLXML, file of 2026-06-16 (ipgb20260616.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Baylor College of Medicine 276 patentsUS company or organizationHouston, TXBaylor College of Medicine College or university EXACT high confidence: identical full name and state
BAYLOR COLLEGE OF MEDICINE Nonprofit EXACT high confidence: identical full name and state
PTBLXML, file of 2026-06-16

Inventors

InventorPlacePatentsPerson pageSource
Zhechao RuanHouston, TX2PTBLXML, file of 2026-06-16
Kilian GuseHamburg, DE3PTBLXML, file of 2026-06-16
Brendan LeeHouston, TX13PTBLXML, file of 2026-06-16

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/86PTBLXML, file of 2026-06-16
A61KPreparations for medical, dental or toiletry purposesA61K48/0058PTBLXML, file of 2026-06-16

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-07-04Security interest Security interest
Security interest
PACIRA THERAPEUTICS, INC. signed 2025-07-03WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT SAN ANTONIO, TX71609/342PASDL, file of 2026-10-15
2021-07-02Assignment
Assignment of assignor's interest
RUAN, ZHECHAO signed 2015-09-17
GUSE, KILIAN signed 2015-07-29
LEE, BRENDAN signed 2015-08-14
BAYLOR COLLEGE OF MEDICINE HOUSTON, TX56747/920PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.